Tafadine Eye Drops 0.2% (Olopatadine Hydrochloride) (Single Use)

Adult eye dose

1 drop at a time, once a day.

This medication should not be used by those who have allergic reactions to the active or inactive ingredients. Symptoms of the nervous system such as headaches, taste disturbances, and dizziness may occur while using this medication. Eye-related symptoms, such as keratitis, eye pain, dry eyes, eye itching, and eye redness, may rarely occur. It may also cause nasal dryness or symptoms of rhinitis, and reports of dry mouth have been noted. There is a possibility of developing allergic dermatitis on the skin, and fatigue may also be experienced. Similar symptoms to cold or pharyngitis can occur in about 10% of patients, with symptoms such as weakness, back pain, frequent coughing, and nausea persisting in some patients. Caution is required as the phosphate component included in this medication can rarely cause calcification-related damage to the cornea. This medication should not be used in relation to contact lens irritation, and the ingredient benzalkonium chloride may discolor contact lenses, so lenses should not be worn for at least 15 minutes after instillation. Temporary blurriness of vision may occur after instillation, so one should wait until vision returns to normal before driving or operating machinery. Pregnant women should use this medication cautiously, as it may affect the fetus, and breastfeeding women should also be careful as the medication may pass to the baby. It can be safely used in children aged 3 years and older, and elderly individuals can use it without special precautions. This medication is for ophthalmic use only and should not be used orally or intravenously. To prevent contamination, do not let the tip of the container touch the eye directly, and after use, securely close the lid for storage. When using other eye drops, maintain an interval of at least 5 minutes, and if using eye ointment, apply it last. Single-use products should be used immediately after opening and if it's the first use, discard 1-2 drops to remove any container fragments. In cases of overdose, appropriate monitoring and treatment are required, and systemic administration of this medication has not been reported. This medication has a low risk of carcinogenicity or mutagenicity and is considered safe when used within the normal range.

Mild side effects

• Headache
• taste disturbances
• dizziness
• punctate keratitis
• keratitis
• eye pain
• dry eyes
• eyelid edema
• itchy eyes
• eye discharge

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to keep it in a cool place at a temperature between 2 to 25 degrees. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance

A colorless to pale yellow liquid in a colorless transparent plastic bottle for eye drops.

Package unit

0.35 milliliters/tube x 30 tubes